Zobrazeno 1 - 10
of 1 528
pro vyhledávání: ''
Autor:
Hélène Goussault, Sébastien Gendarme, Jean‐Baptiste Assié, Camille Jung, Salomé Epaud, Christelle Algans, Noémie Salaun‐Penquer, Mathilde Rousseau, Andrea Lazatti, Christos Chouaïd
Publikováno v:
Cancer Medicine. 11:5025-5034
Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3-months of the first hospitalization for lung cancer in France.This an
Autor:
Giuseppe Lamberti, Elisa Andrini, Giambattista Siepe, Cristina Mosconi, Valentina Ambrosini, Claudio Ricci, Paola Valeria Marchese, Gianluca Ricco, Riccardo Casadei, Davide Campana
Publikováno v:
Cancer Medicine. 11:4204-4213
Background: After radical resection of a nonmetastatic Merkel cell carcinoma (M0 MCC), postoperative radiation therapy (RT) is recommended as it improves survival. However, the role of RT in specific subgroups of M0 MCC is unclear. We sought to ident
Autor:
Steven Ades, Bhargavi Pulluri, Chris E. Holmes, Inder Lal, Santosh Kumar, Benjamin Littenberg
Publikováno v:
Cancer Medicine. 11:1817-1826
The relationship between metastatic colorectal cancer (mCRC) and venous thromboembolism (VTE) is poorly defined in the modern era. Our objective was to examine impact of putative risk factors including newer treatments and anti-angiogenic therapy on
Autor:
Hussein Tawbi, Tu My To, Karen Bartley, Natalia Sadetsky, Elizabeth Burton, Lauren Haydu, Edward McKenna
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 139-150 (2022)
Cancer Medicine
Cancer Medicine
Background Patients with melanoma and central nervous system (CNS) metastases have poor survival outcomes. We investigated real‐world treatment patterns and overall survival (OS) of patients with melanoma and CNS metastases. Methods A retrospective
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 392-405 (2022)
Cancer Medicine
Cancer Medicine
Background Anal squamous cell carcinoma (ASCC) is the main subtype of anal cancer and has great heterogeneity in prognosis. We aimed to construct a nomogram for predicting their 1‐, 3‐, and 5‐year overall survival (OS) rates. Methods Patients w
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 492-506 (2022)
Cancer Medicine
Cancer Medicine
Background and Aims Cancer‐associated stroma (CAS) is emerging as a key determinant of metastasis in colorectal cancer (CRC); however, little is known about CAS in colorectal liver metastases (CRLM). This study aimed to validate the prognostic sign
Autor:
Yan Yuan, Zhifan Zeng, Rong-Zhen Li, Weiwei Xiao, Hui Chang, Qiaoxuan Wang, Yuanhong Gao, Wei-Hao Xie
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 117-127 (2022)
Cancer Medicine
Cancer Medicine
Background Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC in South China in the past half‐century. Methods This stud
Autor:
Tadashi Yoshino, Naoya Nakamura, Misa Sakamoto, Tomoka Ikeda, Yuria Egusa, Yoshito Nishimura, Yasuharu Sato, Azusa Fujita, Misato Doi, Noriko Iwaki, Asami Nishikori, Midori Filiz Nishimura, Yuka Gion
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 417-432 (2022)
Cancer Medicine
Cancer Medicine
Background Most patients with methotrexate‐associated lymphoproliferative disorder (MTX‐LPD) show diffuse large B‐cell lymphoma (DLBCL) or classic Hodgkin lymphoma (CHL) types. Patients with MTX‐LPD often have spontaneous remission after MTX
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 21-27 (2022)
Cancer Medicine
Cancer Medicine
Background Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on their infect
Autor:
Ke Wang, Lin Lei, Ji Peng, Jinrong Xiao, Guanzhong Lu, Sheng Wei, Jiao Huang, Yangkai Li, Ying Liu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 281-294 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 281-294 (2022)
Background Lung cancer is the leading cause of cancer morbidity and mortality worldwide, however, the individualized treatment is still unsatisfactory. DNA methylation can affect gene regulation and may be one of the most valuable biomarkers in predi